跳至主要内容
临床试验/EUCTR2013-004355-20-GB
EUCTR2013-004355-20-GB进行中(未招募)1 期

Randomised, controlled crossover trial to evaluate the Effects of Ambulatory Oxygen on health status in patients with Fibrotic Lung Disease (FLD) - Ambulatory oxygen and health status in patients with lung fibrosis

Royal Brompton and Harefield NHS Foundation Trust0 个研究点目标入组 0 人开始时间: 2014年3月31日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Fibrotic Lung diseaseDisease (FLD) patients aged 18 – 99 yrs
  • 2.Desaturation = 88% on a 6MWT on room air
  • 3.Stable respiratory symptoms in the 4 weeks preceding the trial
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • 1.Patients meeting criteria for long term oxygen therapy, including hypercapnic patients
  • 2.Patients expected to change treatment during the course of the study
  • 3.Significant locomotor or communication difficulties
  • 4.Patients with sarcoidosis or connective tissue disease affecting the musculoskeletal system
  • 5.Current smokers
  • 6. Pregnancy

研究者

相似试验